Trials / Recruiting
RecruitingNCT06787560
CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases
Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allogeneic Hematopoietic Stem Cell Transplantation for Non-malignant Blood and Immune System Diseases
- Status
- Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Zhejiang University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A Clinical Study on the Safety and Effectiveness of CD7 CAR-T Cell Sequential Allogeneic Hematopoietic Stem Cell Transplantation for Non-malignant Blood and Immune System Diseases
Detailed description
This is a single-arm, open-label clinical trial to evaluate the safety and efficacy of CD7 CAR-T Cell Sequential Allogeneic Hematopoietic Stem Cell Transplantation for Non-malignant Blood and Immune System Diseases. It is planned to enroll 12-20 participants in this trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | CD7 CAR-T cells injection | Each subject receive CD7 CAR T-cells by intravenous infusion |
| PROCEDURE | Allo-HSCT | allogeneic hematopoietic stem cell transplantation |
Timeline
- Start date
- 2025-01-31
- Primary completion
- 2028-01-31
- Completion
- 2028-01-31
- First posted
- 2025-01-22
- Last updated
- 2025-01-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06787560. Inclusion in this directory is not an endorsement.